<code id='6E39BFEDE8'></code><style id='6E39BFEDE8'></style>
    • <acronym id='6E39BFEDE8'></acronym>
      <center id='6E39BFEDE8'><center id='6E39BFEDE8'><tfoot id='6E39BFEDE8'></tfoot></center><abbr id='6E39BFEDE8'><dir id='6E39BFEDE8'><tfoot id='6E39BFEDE8'></tfoot><noframes id='6E39BFEDE8'>

    • <optgroup id='6E39BFEDE8'><strike id='6E39BFEDE8'><sup id='6E39BFEDE8'></sup></strike><code id='6E39BFEDE8'></code></optgroup>
        1. <b id='6E39BFEDE8'><label id='6E39BFEDE8'><select id='6E39BFEDE8'><dt id='6E39BFEDE8'><span id='6E39BFEDE8'></span></dt></select></label></b><u id='6E39BFEDE8'></u>
          <i id='6E39BFEDE8'><strike id='6E39BFEDE8'><tt id='6E39BFEDE8'><pre id='6E39BFEDE8'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:focus    Page View:5923
          Tome cofounders Jonathan Gootenberg, left, and Omar Abudayyeh, a scientific team that's trying to reinvent gene editing for a new era of biotech innovation.
          Suzanne Kreiter/Globe staff

          WATERTOWN — Their brainstorming began in an MIT class in 2010 when the eager undergrads shot each other emails about how to solve a bioengineering equation. It has continued for 14 years over sushi dinners, between Marvel movies, and during rowing-machine workouts.

          Together, Omar Abudayyeh, 33, and Jonathan Gootenberg, 32, have probed the mysteries of genomic editing and COVID detection. They co-published 10 scientific papers, helped launch two medical-diagnostic companies, and cofounded a Watertown startup, Tome Biosciences, that reengineers genes and cells to cure diseases. They also run the Abudayyeh-Gootenberg Lab at Harvard.

          advertisement

          Gootenberg and Abudayyeh are an unusual pair, two scientists — a Jewish American and a Palestinian American — who prefer working together in a field that often draws solitary researchers and rewards individual achievement.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

          CMSAdministratorChiquitaBrooks-LaSureChipSomodevilla/GettyImagesWASHINGTON— EliLilly’slatestanti-amy

          read more
          Medicare isn't yet testing food as medicine
          Medicare isn't yet testing food as medicine

          AdobeWASHINGTON–SometwelvepercentoftraditionalMedicarebeneficiarieshaveheartfailure.Roughlyaquarterh

          read more
          Sports medicine is finally prioritizing gender equality
          Sports medicine is finally prioritizing gender equality

          MollyFergusonforSTATWhencyclistAlisonTetrickjoinedthesport’sprofessionalranks,shereceivedtheperkstha

          read more

          Covid overtakes 1918 Spanish flu as deadliest disease in U.S. history

          VolunteernursesfromtheAmericanRedCrosstendtoinfluenzapatientsintheOaklandMunicipalAuditorium,usedasa